Ellipses Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Ellipses Pharma?

Ellipses Pharma is funded by West Coast Capital.

Q: When was the last funding round for Ellipses Pharma?

Ellipses Pharma closed its last funding round on obfuscated from a Private Equity round.

Overview

Ellipses Pharma

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ellipses Pharma

CB Rank

211159

Ellipses Pharma is a drug development business specializing in the creation of novel cancer drugs and therapies.

Founded

obfuscation

Private

Private Equity

London, England, United Kingdom

11-50

ellipses.life/

Biotechnology

Funding Rounds

Private Equity

OBF

obfuscation

Details

Legal Name

Ellipses Pharma Limited

Operating Status

Active

Company Type

For Profit

About the Company

Ellipses Pharma is a drug development business specializing in the creation of novel cancer drugs and therapies. Ellipses invests in cancer assets, not companies. Its goal is to bring these exceptional assets into the clinic as soon as possible in order to create more possibilities, run more studies, and save more lives.

Predictions & Insights

Growth Insight

See this Growth Insight

Ellipses Pharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

EP0031

A selective RET inhibitor currently in Phase 1/2 clinical trials for patients with advanced RET-altered malignancies.

Drug Development Model

A model that combines unbiased vetting of potential drug candidates with uninterrupted capital flow to minimize clinical trial time.

Research & Development

Ellipses Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Ellipses Pharma	1	obfuscated obfuscation	West Coast Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Ellipses Pharma	1	obfuscated obfuscation	West Coast Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Ellipses Pharma	1	obfuscated obfuscation	West Coast Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Ellipses Pharma	1	obfuscated obfuscation	West Coast Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Ellipses Pharma	1	obfuscated obfuscation	West Coast Capital	Private Equity

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Ellipses Pharma	1	obfuscated obfuscation	West Coast Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Ellipses Pharma	1	obfuscated obfuscation	West Coast Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Ellipses Pharma	1	obfuscated obfuscation	West Coast Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Ellipses Pharma	1	obfuscated obfuscation	West Coast Capital	Private Equity
obfuscated obfuscation	Private Equity Round - Ellipses Pharma	1	obfuscated obfuscation	West Coast Capital	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
West Coast Capital	Yes	Private Equity Round - Ellipses Pharma	Sir Tom Hunter
West Coast Capital	Yes	Private Equity Round - Ellipses Pharma	Sir Tom Hunter
West Coast Capital	Yes	Private Equity Round - Ellipses Pharma	Sir Tom Hunter
West Coast Capital	Yes	Private Equity Round - Ellipses Pharma	Sir Tom Hunter
West Coast Capital	Yes	Private Equity Round - Ellipses Pharma	Sir Tom Hunter